Pomanda estimates the enterprise value of GLENHOLME SPECIALIST HEALTHCARE (SOUTHERN REGION) LIMITED at £3.3m based on a Turnover of £5.3m and 0.62x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of GLENHOLME SPECIALIST HEALTHCARE (SOUTHERN REGION) LIMITED at £8.9m based on an EBITDA of £1.7m and a 5.25x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of GLENHOLME SPECIALIST HEALTHCARE (SOUTHERN REGION) LIMITED at £12.4m based on Net Assets of £4.7m and 2.66x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Glenholme Specialist Healthcare (southern Region) Limited is a live company located in windsor, SL4 6AF with a Companies House number of 05757165. It operates in the other residential care activities n.e.c. sector, SIC Code 87900. Founded in March 2006, it's largest shareholder is
glenholme healthcare group limited
with a 100% stake. Glenholme Specialist Healthcare (southern Region) Limited is a established,
mid sized company, Pomanda has estimated its turnover at
£5.3m with
high
growth in recent years.
Glenholme Specialist Healthcare (southern Region) Limited Health Check
Pomanda's financial health check has awarded Glenholme Specialist Healthcare (Southern Region) Limited a 4 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 4 areas for improvement. Company Health Check FAQs
Health Rating4out of 5
5 Strong
3 Regular
4 Weak
Size
annual sales of £5.3m, make it larger than the average company (£2.3m)
Glenholme Specialist Healthcare (Southern Region) Limited's latest turnover from March 2024 is £5.3 million and the company has net assets of £4.7 million. According to their latest financial statements, Glenholme Specialist Healthcare (Southern Region) Limited has 124 employees and maintains cash reserves of £6 thousand as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Mar 2020
Mar 2019
Mar 2018
Mar 2017
Mar 2016
Mar 2015
May 2014
May 2013
May 2012
May 2011
May 2010
Turnover
5,272,523
4,241,711
3,479,219
3,049,152
2,652,864
2,154,405
1,267,711
738,926
721,058
672,400
804,453
2,297,904
4,157,783
3,612,029
3,592,251
Other Income Or Grants
Cost Of Sales
3,606,539
3,270,567
2,555,291
2,357,211
1,884,641
1,434,789
986,585
555,143
560,525
468,745
422,316
1,601,786
2,794,377
2,398,105
2,360,412
Gross Profit
1,665,984
971,144
923,928
691,941
768,223
719,616
281,126
183,783
160,533
203,655
382,137
696,119
1,363,406
1,213,924
1,231,840
Admin Expenses
53,024
-574,848
632,572
-238,087
-67,470
346,321
90,602
65,502
21,692
20,961
156,303
541,500
1,225,563
1,119,211
1,851,972
Operating Profit
1,612,960
1,545,992
291,356
930,028
835,693
373,295
190,524
118,281
138,841
182,694
225,834
154,619
137,843
94,713
-620,132
Interest Payable
372,758
186,871
128,863
134,421
118,935
64,659
55,215
52,928
56,691
54,535
64,000
50,882
37,916
19,908
Interest Receivable
192,285
21
1
42
42
Pre-Tax Profit
1,240,202
1,359,121
162,493
795,607
716,758
308,636
135,309
65,353
82,150
129,149
357,292
103,758
99,928
74,847
-620,090
Tax
-318,376
-329,812
-99,294
-169,842
-144,795
-64,828
-32,757
-23,349
-19,400
-26,563
-23,864
-23,983
-19,460
Profit After Tax
921,826
1,029,309
63,199
625,765
571,963
243,808
102,552
42,004
62,750
102,586
357,292
79,894
75,945
55,387
-620,090
Dividends Paid
Retained Profit
921,826
1,029,309
63,199
625,765
571,963
243,808
102,552
42,004
62,750
102,586
357,292
79,894
75,945
55,387
-620,090
Employee Costs
3,069,715
2,408,191
1,751,966
1,694,560
1,233,564
837,542
629,400
320,767
400,941
354,291
363,929
964,625
1,804,392
1,551,691
1,588,667
Number Of Employees
124
123
82
82
57
42
31
20
22
21
18
50
92
79
81
EBITDA*
1,692,007
1,622,295
375,320
1,025,312
919,232
440,554
240,962
142,314
166,298
185,508
229,835
161,240
156,673
117,403
-606,569
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Mar 2020
Mar 2019
Mar 2018
Mar 2017
Mar 2016
Mar 2015
May 2014
May 2013
May 2012
May 2011
May 2010
Tangible Assets
3,214,214
3,176,770
3,210,013
3,259,764
3,275,974
5,153,647
3,454,980
2,360,424
1,199,045
1,222,355
1,180,316
1,182,577
1,182,398
1,177,046
1,188,338
Intangible Assets
4
4
4
2,712
12,884
23,056
Investments & Other
4,825,000
4,826,750
3,725,000
4,028,011
3,363,484
Debtors (Due After 1 year)
Total Fixed Assets
8,039,214
8,003,520
6,935,013
7,287,775
6,639,458
5,153,647
3,454,980
2,360,424
1,199,045
1,222,359
1,180,320
1,182,581
1,185,110
1,189,930
1,211,394
Stock & work in progress
2,985
2,275
2,127
2,500
1,850
975
475
479
300
300
300
300
300
300
300
Trade Debtors
492,639
407,838
169,844
133,113
148,345
48,423
74,532
28,917
43,892
60,143
86,197
95,112
59,965
59,329
48,868
Group Debtors
2,209,625
36,678
Misc Debtors
5,857
44,559
43,075
42,613
53,726
106,740
29,902
8,562
4,873
2,909
5,234
Cash
6,000
89,047
263,864
433,048
464,142
63,454
20,211
58,600
21,456
21,504
1,369
8,349
79
196
16,778
misc current assets
total current assets
2,717,106
543,719
478,910
611,274
668,063
219,592
125,120
96,558
107,199
84,856
93,100
103,761
60,344
59,825
65,946
total assets
10,756,320
8,547,239
7,413,923
7,899,049
7,307,521
5,373,239
3,580,100
2,456,982
1,306,244
1,307,215
1,273,420
1,286,342
1,245,454
1,249,755
1,277,340
Bank overdraft
299,658
152,212
215,050
220,203
184,896
95,206
100,438
56,584
50,030
98,992
41,502
Bank loan
Trade Creditors
58,373
89,069
31,376
8,342
386
506,047
958,249
986,345
1,016,542
Group/Directors Accounts
556,235
660,325
1,059,645
1,056,828
1,964,664
1,175,489
1,180,015
other short term finances
hp & lease commitments
11,858
other current liabilities
83,166
57,934
39,417
43,353
34,138
20,376
6,250
5,350
38,083
50,111
134,525
total current liabilities
453,055
855,450
946,168
1,323,201
1,275,862
2,080,246
1,282,177
1,241,949
88,113
157,445
176,413
506,047
958,249
986,345
1,016,542
loans
5,027,781
3,364,728
3,474,638
3,661,729
3,884,132
1,819,567
1,909,905
1,009,101
1,060,701
1,054,042
961,960
1,011,504
554,094
612,563
hp & lease commitments
19,763
Accruals and Deferred Income
other liabilities
184,169
175,205
219,419
213,100
878,438
provisions
601,064
592,843
314,247
322,136
181,309
79,171
5,028
7,563
1,065
2,113
total long term liabilities
5,648,608
3,957,571
3,788,885
3,983,865
4,065,441
1,898,738
1,914,933
1,016,664
1,061,766
1,056,155
1,146,129
1,186,709
773,513
825,663
878,438
total liabilities
6,101,663
4,813,021
4,735,053
5,307,066
5,341,303
3,978,984
3,197,110
2,258,613
1,149,879
1,213,600
1,322,542
1,692,756
1,731,762
1,812,008
1,894,980
net assets
4,654,657
3,734,218
2,678,870
2,591,983
1,966,218
1,394,255
382,990
198,369
156,365
93,615
-49,122
-406,414
-486,308
-562,253
-617,640
total shareholders funds
4,654,657
3,734,218
2,678,870
2,591,983
1,966,218
1,394,255
382,990
198,369
156,365
93,615
-49,122
-406,414
-486,308
-562,253
-617,640
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Mar 2020
Mar 2019
Mar 2018
Mar 2017
Mar 2016
Mar 2015
May 2014
May 2013
May 2012
May 2011
May 2010
Operating Activities
Operating Profit
1,612,960
1,545,992
291,356
930,028
835,693
373,295
190,524
118,281
138,841
182,694
225,834
154,619
137,843
94,713
-620,132
Depreciation
79,047
76,303
83,964
95,284
83,539
67,259
50,438
24,033
27,457
2,814
4,001
3,913
8,658
12,518
13,563
Amortisation
2,708
10,172
10,172
Tax
-318,376
-329,812
-99,294
-169,842
-144,795
-64,828
-32,757
-23,349
-19,400
-26,563
-23,864
-23,983
-19,460
Stock
710
148
-373
650
875
500
-4
179
300
Debtors
2,255,724
239,478
37,193
-26,345
46,908
50,729
66,955
-47,964
22,391
-28,379
-3,681
35,147
636
10,461
48,868
Creditors
-30,696
57,693
31,376
-8,342
7,956
-505,661
-452,202
-28,096
-30,197
1,016,542
Accruals and Deferred Income
25,232
18,517
-3,936
9,215
13,762
14,126
900
-32,733
-12,028
-84,414
134,525
Deferred Taxes & Provisions
8,221
278,596
-7,889
140,827
102,138
74,143
-2,535
6,498
-1,048
2,113
Cash flow from operations
-880,046
1,407,663
258,757
1,031,207
842,554
412,766
139,619
140,515
103,089
112,979
-137,620
-349,973
103,958
57,285
360,805
Investing Activities
capital expenditure
-116,491
-43,060
-34,213
-79,074
1,794,134
-1,765,926
-1,144,994
-1,185,412
-4,143
-44,853
-1,740
-4,092
-14,010
-1,226
-1,224,957
Change in Investments
-1,750
1,101,750
-303,011
664,527
3,363,484
cash flow from investments
-114,741
-1,144,810
268,798
-743,601
-1,569,350
-1,765,926
-1,144,994
-1,185,412
-4,143
-44,853
-1,740
-4,092
-14,010
-1,226
-1,224,957
Financing Activities
Bank loans
Group/Directors Accounts
-556,235
-104,090
-399,320
2,817
-907,836
789,175
-4,526
1,180,015
Other Short Term Loans
Long term loans
1,663,053
-109,910
-187,091
-222,403
2,064,565
-90,338
900,804
-51,600
6,659
92,082
-49,544
457,410
-58,469
612,563
Hire Purchase and Lease Commitments
31,621
other long term liabilities
-184,169
8,964
-44,214
6,319
-665,338
878,438
share issue
-1,387
26,039
23,688
767,457
82,069
40,151
2,450
interest
-372,758
-186,871
-128,863
-134,421
-118,935
-64,659
-55,215
-52,928
-56,691
-54,535
128,285
-50,861
-37,915
-19,866
42
cash flow from financing
764,294
-374,832
-691,586
-354,007
1,037,794
1,401,635
923,132
1,075,487
-50,032
-106,471
87,705
362,335
-90,065
-72,641
880,930
cash and cash equivalents
cash
-83,047
-174,817
-169,184
-31,094
400,688
43,243
-38,389
37,144
-48
20,135
-6,980
8,270
-117
-16,582
16,778
overdraft
147,446
-62,838
-5,153
35,307
89,690
-5,232
43,854
6,554
-48,962
57,490
41,502
change in cash
-230,493
-111,979
-164,031
-66,401
310,998
48,475
-82,243
30,590
48,914
-37,355
-48,482
8,270
-117
-16,582
16,778
glenholme specialist healthcare (southern region) limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for glenholme specialist healthcare (southern region) limited. Get real-time insights into glenholme specialist healthcare (southern region) limited's credit score, group structure and payment trends.
Perform a competitor analysis for glenholme specialist healthcare (southern region) limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other mid companies, companies in SL4 area or any other competitors across 12 key performance metrics.
Glenholme Specialist Healthcare (Southern Region) Limited currently has 3 directors.
The longest serving directors include
Mr Don Serratt (Nov 2014) and
Mr Kent Phippen (Nov 2014).
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 10 charges/mortgages relating to glenholme specialist healthcare (southern region) limited. Currently there are 5 open charges and 5 have been satisfied in the past.
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for GLENHOLME SPECIALIST HEALTHCARE (SOUTHERN REGION) LIMITED. This can take several minutes, an email will notify you when this has completed.
glenholme specialist healthcare (southern region) limitedCompanies House Filings - See Documents
